Skip to Main Content

Author Details

Camille R Simoneau
Gladstone Institute of Virology
2015
29
17
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36827975SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants.Stem Cell Reports2023
37938000Hepatitis C virus infects and perturbs liver stem cells.mBio2023
36603024Nuclear accumulation of host transcripts during Zika Virus Infection.PLoS Pathog2023
35232252Modelling T-cell immunity against hepatitis C virus with liver organoids in a microfluidic coculture system.Open Biol2022
35584773Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination.Nature2022
35611333Immediate myeloid depot for SARS-CoV-2 in the human lung.Res Sq2022
35670478Impact of e-cigarette aerosol on primary human alveolar epithelial type 2 cells.Am J Physiol Lung Cell Mol Physiol2022
35858406Tropism of SARS-CoV-2 for human cortical astrocytes.Proc Natl Acad Sci U S A2022
35592107Immediate myeloid depot for SARS-CoV-2 in the human lung.bioRxiv2022
35982664NF-κB inhibitor alpha has a cross-variant role during SARS-CoV-2 infection in ACE2-overexpressing human airway organoids.bioRxiv2022
33469577Tropism of SARS-CoV-2 for Developing Human Cortical Astrocytes.bioRxiv2021
33758899Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation.medRxiv2021
33723017SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19.Sci Transl Med2021
33991487Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.Cell2021
34100012SARS-CoV-2 infection studies in lung organoids identify TSPAN8 as novel mediator.bioRxiv2021
33333024Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.Cell2021
32817938An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation.bioRxiv2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
33275899Modeling Multi-organ Infection by SARS-CoV-2 Using Stem Cell Technology.Cell Stem Cell2020
33154106An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.Science2020
33232663Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men.Cell Stem Cell2020
32995787Functional genomic screens identify human host factors for SARS-CoV-2 and common cold coronaviruses.bioRxiv2020
32935097SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients.bioRxiv2020
29921650NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantation.Blood Adv2018
30032204Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection.Ann Oncol2018
28704647HIV-1-Mediated Downmodulation of HLA-C Impacts Target Cell Recognition and Antiviral Activity of NK Cells.Cell Host Microbe2017
27094484Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication.J Immunol Methods2016
27455421Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1.Nat Immunol2016
26680341Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B*57:01.PLoS One2015
  • 1 - 29 of 29

Recommended Authors

The Scripps Research Institute
Career Start Year 2018
Number of shared co-authors 27
Hanover Medical School
Career Start Year 2017
Number of shared co-authors 36
Icahn School of Medicine at Mount Sinai
Career Start Year 2015
Number of shared co-authors 4
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 4
Yale University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Institut Pasteur, Universite Paris Cite, CNRS UMR 9
Career Start Year 2012
Number of shared co-authors 39
Yale University
Career Start Year 2012
Number of shared co-authors 0
University of California berkeley
Career Start Year 2011
Number of shared co-authors 6
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 14
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 11
Yale University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 8
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 3
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 3
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 2
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 46
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 5
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year 2006
Number of shared co-authors 2
Duke-NUS Medical School
Career Start Year 2003
Number of shared co-authors 10
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2003
Number of shared co-authors 31
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 7
University of North Carolina at Chapel Hill
Career Start Year 2002
Number of shared co-authors 2
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 4
The Scripps Research Institute
Career Start Year 2001
Number of shared co-authors 32
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 6
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1997
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 1997
Number of shared co-authors 1
University College London
Career Start Year 1992
Number of shared co-authors 17
Yale University
Career Start Year 1990
Number of shared co-authors 6

Collaborators

Gladstone Institute of Virology
Co-authored papers 21
Gladstone Institutes
Co-authored papers 8
University of California San Francisco
Co-authored papers 7
Gladstone Institutes
Co-authored papers 6
University of California san francisco
Co-authored papers 6
Cardiovascular Research Institute, University of California san francisco
Co-authored papers 6
Gladstone Institutes
Co-authored papers 5
University of California at San Francisco
Co-authored papers 5
Gladstone Institutes
Co-authored papers 5
Co-authored papers 4
J. David Gladstone Institutes
Co-authored papers 4
J. David Gladstone Institutes
Co-authored papers 4
University of California san francisco
Co-authored papers 4
Gladstone Institute of Cardiovascular Disease
Co-authored papers 4
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 3
Gladstone Institute of Virology
Co-authored papers 3
Department of Pharmaceutical Chemistry, University of California-San Francisco
Co-authored papers 3
University of California san francisco
Co-authored papers 3
University of California san francisco
Co-authored papers 3
Synthego Corporation
Co-authored papers 3
University of California san francisco
Co-authored papers 3
Howard Hughes Medical Institute, University of California los angeles
Co-authored papers 3
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 3
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 3
University of California San Francisco (UCSF) School of Medicine
Co-authored papers 3
Fred Hutchinson Cancer Center
Co-authored papers 3
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 3
Shanghai Clinical Research and Trial Center
Co-authored papers 3
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 3
University of California san francisco
Co-authored papers 3